A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(28 sites)

United States

Children's Hospital of Alabama, Birmingham, Alabama

UCSF Benioff Children's Hospital Oakland, Oakland, California

UCSF Medical Center-Mission Bay, San Francisco, California

Children's Hospital Colorado, Aurora, Colorado

Alfred I duPont Hospital for Children, Wilmington, Delaware